Is Pfizer (PFE.US) stock worth buying? A latest outlook on the stock's prospects.
Pfizer (PFE.US) is a research-based, global biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, sales, and distribution of biopharmaceutical products worldwide.
For investors, the core of investment decision‑making lies in accurately assessing a company’s growth potential. So, is PFE.US truly worth buying at this time?As a leading financial information service provider, Futubull integrates rating information on each stock from numerous renowned global securities research institutions.It aims to provide users with a comprehensive and timely view of market consensus, helping you accurately identify the optimal entry point.
■According to the latest [Major Brokerage Ratings] data compiled by Futubull (as of April 24, 2026)
Futubull provides you with professional stock analysis and investment decision support.
In addition to ratings from professional institutions, Futubull takes you, from the perspective of a professional investor, to utilize the “Three-Step Analysis Method” to...Company business, performance status, and technical indicatorsThree core dimensions for a deep dive into stocks, helping you determine whether PFE.US is worth buying.
■Company Business: What does Pfizer do?
Pfizer (PFE.US) is a research-based, global biopharmaceutical company founded in 1849 and headquartered in New York, USA. The company was listed on the New York Stock Exchange on January 17, 1944. Its operations span the globe, covering the discovery, development, manufacturing, marketing, sales, and distribution of biopharmaceutical products, with a commitment to promoting health and preventing and treating various diseases in both developed and emerging markets.
Biopharmaceuticals
According to data for the fourth quarter of 2025, biopharmaceuticals constitute the company's core business, accounting for 97.64% of total revenue, with a focus on drug discovery, development, manufacturing, marketing, sales, and distribution.
Hospital medications
The company provides sterile injectable solutions and anti-infective drugs for the treatment of infections and allergic reactions, among other conditions; its COVID-19 oral medication, Paxlovid, is also included in this business segment.
Inflammation and Immunology
Provides medications for the treatment of chronic immune and inflammatory diseases, indicated for conditions such as rheumatoid arthritis, psoriatic arthritis, and atopic dermatitis, with Xeljanz being a prominent brand.
Futubull tooltip:
Facing fragmented information, want to quickly grasp the key priorities of your company’s business?
Simply open the Futubull app, tap the “Company” tab, and scroll down to view Pfizer’s “Business Segment Breakdown,” where you can clearly and intuitively see Pfizer’s main businesses, core products, and market share, helping you quickly analyze the company’s fundamentals.
Futubull breaks down the core business of listed companies for you, helping you understand their fundamentals.
■Performance Dimension: Is Pfizer Making Money?
Futubull's "Earnings Calendar" shows that Pfizer is… 2026/5/5Publish 2026 Q1Performance.
At the same time, Futubull’s “Performance Express” module has compiled the following key performance data for your reference:
| Project | Core data for the quarter | Key changes |
|---|---|---|
| Operating revenue | 17.557 billion USD | Down 1.16% year-on-year, but still above the market's expectation of US$16.828 billion. |
| Loss per share | US$0.29 | Year-on-year loss of 514.29%, below market expectations of $0.39 per share. |
| Net loss attributable to owners of the parent company | US$1.648 billion | Down 501.95% year-on-year, turning from profit to loss |
| Gross profit margin | 69.97% | An increase of 4.85 percentage points year-on-year. |
| Cash flow from operating activities | US$5.348 billion | Down 20.43% year-on-year |
Pfizer's latest financial results are out, but with such a dense pile of financial reports, do you find yourself too busy to read them in detail—and even more difficult to quickly assess what the data actually means?Major positive newsStillHidden RisksIf you lack the proper interpretation of financial reports, you’ll miss out.Best buying and selling pointsIf there were a reliable tool to help interpret financial reports, it would greatly assist you during earnings season.Seize the initiative and reap profits with ease.。
Futubull's "Performance Express" feature:
Transform complex financial reports into clear, concise insights, enabling you to grasp key data such as revenue and earnings per share—and determine within minutes whether these figures “exceeded expectations” or “fell short of market expectations.”
✓ Positive signal:If the earnings report shows that revenue and net profit significantly outperform market expectations, it generally indicates strong underlying fundamentals for the company. Investors can assess current market conditions and their own risk tolerance to identify potential investment opportunities or make appropriate adjustments to their portfolios.
✓ Risk signal:If key financial indicators show weak performance (or all decline), and both revenue and earnings per share fall short of expectations, this may signal a slowdown in growth. Investors should carefully assess the risks associated with their holdings and, in light of their investment strategies, consider adjusting their portfolio allocations or adopting a wait-and-see approach.
In short, regardless of whether the performance is good or bad, Futubull’s “Performance Express” feature can instantly interpret key data for you, allowing you to confidently enter the market and place orders without having to painstakingly pore over densely packed financial reports.
Open the Futubull App > Individual Stock Page > [Company] Tab—Performance Express—to use this feature for free!
Futubull dissects key financial report data to help you identify buying and selling opportunities before and after earnings releases.
■Technical Indicators: What is the current market sentiment toward Pfizer (PFE.US)?
The financial data analyzed in “Performance Express” can help you gain a clear understanding of a company’s long‑term growth potential and underlying value; however, to accurately time your entry into a complex market, you still need…Technical IndicatorsProvided real-time signals. Only by anchoring long-term direction with fundamental analysis and locking in short-term opportunities with technical analysis can investment decisions become more stable and more accurate.
Pfizer (PFE.US) currently shows one "buy signal" and one "sell signal."
"Optimistic"The RSI(6), CCI, and WMSR have moved from the neutral zone into oversold territory, indicating potential rebound opportunities.
Let it go.The MA5 has crossed below the MA10 and MA60, forming a death cross, which suggests that the price may continue to decline.
For those of you who have to return to work and attend meetings on a daily basis, even though you know that the MACD and RSI are crucial, do you simply not have time to monitor the market around the clock? Or perhaps you’re worried about misinterpreting the indicators and can’t tell the difference between...“True Signal”Still"False Breakout"？No need to slog through technical theories—just let “NiuNiu AI” instantly translate market conditions for you!
Futu SupportAI Real‑Time MonitoringIncluding 15 key indicators such as MACD, KDJ, and RSI, these tools directly “translate” complex chart patterns into simple signals—so you no longer need to delve into what “golden crosses and death crosses” or “top and bottom divergences” actually mean, and you can…Easily Grasp Technical Trends。
After understanding Pfizer (PFE.US)’s technical analysis and forming a preliminary judgment on the overall price trend, to ensure you can react swiftly at critical moments, you may consider using Futubull’s…Price AlertFunction: You can set the following alerts for key areas:
✓ Stock Price Alert: Break above $28.75, break below $26.40
✓ Indicator Alert: RSI(12) breaks above 70, RSI(12) falls below 30
With Futubull AI, you’ll never have to worry about complex technical indicators again! Download Futubull now and let AI translate technical analysis into clear buy/sell signals—easily distinguishing between “bullish” and “bearish.” Investing has never been so simple and straightforward!
AI-powered real-time interpretation of technical indicators—master buying and selling timing.
■Why do investors choose Futu for trading?
Investing is never a one‑time deal; it's a journey that requires long‑term tracking and dynamic adjustments. Perhaps you don't yet have enough capital to buy Pfizer, or perhaps Pfizer isn't worth buying right now, but you can still use Futubull to track Pfizer over the long term.
Open Futubull,Add Pfizer to your wishlist., you will also reap
Performance Release Reminder：
Before each Pfizer earnings release, Futubull will send you a reminder so you don't miss any earnings opportunity
Related News Feed：
Real‑time aggregation of major news such as product launches and board changes, enabling you to promptly capture the key events that impact Pfizer's stock price.
Institutional Holdings Changes：
Track the flow of "smart money" and gain instant insights into the buying and selling activities of major banks and funds in Pfizer.
Stock Price Alert：
Set your desired "psychological price point" and never have to monitor the market around the clock—once Pfizer's stock price pulls back, the system will notify you instantly.
All of the above functions“Free of charge”, download Futubull now and start your professional investment journey!
●Why choose Futu?
Security Assurance
Futu is subject toDual protection from the Hong Kong Investor Compensation Fund (up to HK$500,000) and the U.S. SIPC (up to US$500,000)., all client assets are…Independent Bank Custodyand is equipped with a risk management system developed in-house to ensure data security.
Licensed and compliant
Futu Securities International (Hong Kong) Co., Ltd. isHong Kong’s largest tech-driven brokerage firm (stock code: FUTU)It is also a licensed corporation approved by the Securities and Futures Commission of Hong Kong (CE No.: AZT137).
The company is strictly regulated by the China Securities Regulatory Commission and holds licenses of Class 1, 2, 3, 4, 5, 7, and 9.
Zero-commission trading
Hong Kong stocks, U.S. stocks fractional shares, Crypto0% commission on trades,Help you invest and save more!
Open an account now and enjoy a welcome bonus worth over 1,000 yuan!
Track Pfizer's developments for free and trade Hong Kong/US stocks securely and in compliance with regulations.
The content presented above were generated by AI language model with publicly available information and the above material does not represent the position of the company and shall not constitute any investment advice. You may only use the materials on this website for personal reference and non-commercial purposes. Read More